Expedited Review Decisions Should Be Made Before PMA Submission - HIMA
This article was originally published in The Gray Sheet
Executive Summary
FDA should determine whether a sponsor's premarket submission will be granted expedited review prior to the application being filed with the agency, the Health Industry Manufacturers Association asserts in June 29 comments.